Marshall Wace, LLP Dbv Technologies S.A. Transaction History

Marshall Wace, LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.75 - $6.57 $126,296 - $301,733	-45,926 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.33 - $12.98 $381,619 - $2.13 Million	-163,785 Reduced 78.1%	45,926 $180,000
Q4 2019 Feb 14, 2020	BUY	$6.75 - $11.15 $1.42 Million - $2.34 Million	209,711 New	209,711 $2.24 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $88.3M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.